Society for Pediatric Pathology
Menu

Spring Meeting 2017

The Society conducts a Spring Annual Meeting in conjunction with the U.S.-Canadian division of the International Academy of Pathology (USCAP), attracting large numbers of registrants from both organizations. In addition, the Society holds a Fall Meeting each year at various pediatric institutions throughout North America. The Fall Meeting includes the presentation of papers and a symposium that draws upon the expertise of local faculty. An informal atmosphere allows for interchange among colleagues and an opportunity to visit the institutions of peers. Since 1978 the Society has presented the Sidney Farber Lecture which features an in depth view of current topics in developmental pathology.


2017 Spring Meeting will be in San Antonio, TX

March 3 - 5, 2017
San Antonio Marriott Riverwalk
889 East Market Street
San Antonio, Texas 78205 USA

Spring Meeting Documents

2017 Program Book

2017 Abstract Book

2017 Yogile Photo Album

2017 App download link

2017 Session Handouts

2017 SPP Business Meeting Agenda

2016 SPP Business Meeting Minutes

2017 Pre-Registered Attendee List

Optional Courses and Events

Please also note, additional fees are required to attend Social Programs workshops.

Social Hour & Banquet
Date: Saturday, March 4, 2017
Time: 7:00pm – 11:00 pm
Price: $125

Workshops

On Sunday, March 5, the following workshops will be offered at an additional fee:

  • Workshop Session 1: 1:30 – 3:30 p.m.

A: Pediatric Lung Biopsy: A Pattern-Based Diagnostic Approach & Update on Pathogenesis (3/3)
B: Pediatric Kidney Biopsy Interpretation: Essentials for the Pathologist-on-Call (2/3)
C: Challenges in Pediatric Soft Tissue Pathology: A Case-Based Approach to Selected Difficult Cases (1/3)

  • Workshop Session 2: 4:00 – 6:00 p.m.

D: Pediatric Peripheral Nerve Sheath Tumors: Pathology and Associated Syndromes (3/3)
E: Adding Relevance to the Pediatric Autopsy with Defined Pre-autopsy Goals and Practical Techniques (2/3)
F: Pediatric Gastrointestinal Biopsy: An Update on the Diagnosis and Pathogenesis of Pediatric Upper Gastrointestinal Disease (1/3)

Registration Hours
Friday, March 3 12:00 pm - 6:00 pm
Saturday, March 4 7:00 am - 6:00 pm
Sunday, March 5 7:00 am - 2:00 pm
Poster Presentation Schedule
Friday, March 3 12:00 pm - 5:00 pm Poster Presenter Set-up
Saturday, March 4 7:00 am - 6:00 pm Posters Open
Sunday, March 5 7:00 am - 12:00 pm Posters Open
12:30 pm Poster Dismantle
Exhibit Hours
Friday, March 3 12:00 pm - 5:00 pm Exhibits Set-up
Saturday, March 4 7:00 am - 6:00 pm Exhibits Open
Sunday, March 5 7:00 am - 12:30 pm Exhibits Open
12:30 pm Exhibits Dismantle

Registration

General Registration

On or before 1/5/17

After 1/6/17 and Before 2/7/17

After 2/7/17 and Onsite

SPP Member, Practicing

$550

$600

$650

Non-Member, Practicing

$600

$650

$700

SPP Member, Senior

$535

$585

$635

Non-Member, Senior

$595

$645

$695

SPP Member, Trainee

$315

$315

$315

Non-Member, Trainee

$365

$365

$365

Guest Registration

$150

$150

$150

WORKSHOP REGISTRATION

(Additional registration is required to attend the Workshops)

SPP Member, Practicing

$150

$150

$150

Non-Member, Practicing

$150

$150

$150

SPP Member, Trainee

$100

$100

$100

Non-Member, Trainee

$100

$100

$100

Social Program Registration

Banquet

$125

$125

$125

Registration Form

Advance registration ends February 22, 2017. After this date, participants must register at the meeting in San Antonio. SPP accepts VISA, MasterCard, Discover and checks made payable to the Society for Pediatric Pathology, in U.S. Dollars only.

The SPP registration form can be completed and sent via email to ametzgar@staff.spponline.org or by mail with full payment to the address below:

Mail to:

Society for Pediatric Pathology
One Parkview Plaza
17W110 22nd Street, Suite 800
Oakbrook Terrace, IL 60181 USA

Registration Fees

All speakers, session chairs and meeting attendees are required to pay the registration fee for the Annual Meeting according to SPP policy and fee schedule. Registration and fee schedule apply even when the speaker attends the Annual Meeting for a short time only to present his/her paper or participate in a panel discussion.

Payment Instructions

Registrations must include payment by check (drawn on a U.S. bank), credit card or bank transfer of funds in U.S. dollars. Wire transfers within North America will incur a $30 fee and wire transfers outside of North America will incur a $45 fee. SPP cannot accept registrations by telephone. SPP will not accept registrations without full payment. Caution: If you submit your registration form more than once, it may result in a duplicate charge to your credit card. Send your registration using only one method of payment.

Confirmation Letters

SPP's web-based registration system acknowledges online registrations immediately via email. You will receive a confirmation/receipt to the email address provided in the registration system shortly after your registration is complete.

SPP will confirm registrations received by email and mail within 14 days of receipt via email as well.

Note: SPP is unable to confirm registrations earlier than two weeks after the submission date if you do not provide an email address. If you do not receive confirmation after two weeks, email Amy Metzgar at SPP Headquarters

Cancellation Policy

Notification of cancellation must be submitted in writing. Cancellations received before February 1, 2017, will be refunded, less a $50 cancellation fee. Substitutions are allowed at any time, but must be submitted in writing and must be of the same member status.

Cancellations will be honored, but money will not be refunded after February 1, 2017.

Abstract Submission

Thank you to all of those who have submitted your abstracts, we look forward to seeing all of the winners at the 2017 Spring Meeting.

Education

CONTINUING MEDICAL EDUCATION ACCREDITATION

Accreditation Statement
The Society for Pediatric Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) and The Society for Pediatric Pathology.

Accreditation and Credit Designation
This activity has been approved for AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

International Physicians
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s) ™.

Health Professionals
Health Professional participants (including residents and fellows-in-training) may claim hours to receive a Certificate of Participation for an activity designated for AMA PRA Category 1 Credit(s) ™.

Course Director
Dr. Lili Miles

Program Planning Group
Click here to see a full list of the individual planning group members

Learning Objectives

As a result of this meeting, participants will be able to:

  • Acknowledge recent advancements in research and practice related to the biology, characterization and/or diagnosis of pediatric disease.
  • Identify areas with recent significant advancement in the practice of pediatric pathology.
  • Implement diagnostic and consultative management updates in pediatric pathology into practice.
  • Summarize clinicopathologic differential diagnoses and pathologic processes of perinatal and pediatric disorders and their complications, as well as their treatments and possible outcomes.

Target Audience

  • Pediatric Pathologists
  • Fellows-in-Training
  • Residents (Pathology)
  • Pediatric Gastroenterologists;
  • World renowned researchers in infantile cholestatic liver disease
  • Educational Need

Pediatric pathologists, pediatric pathology fellows, and surgical pathologists who evaluate newborn and infant liver biopsies need a concise, diagnosis-directed, clinicopathologic Symposium on neonatal and infantile cholestatic liver disease in order to appropriately diagnose the entities that comprise this complex group of disorders.

The differential diagnosis of the jaundiced neonate and infant is broader than at any other age. The liver biopsy is a cornerstone of the diagnostic work-up of infants with jaundice, and the wide range of disorders that can cause neonatal cholestasis makes interpretation of these biopsies challenging. The timing and expediency of the workup is in addition considered crucial because outcomes for a number of diagnoses are directly linked to early intervention, most notably biliary atresia. Furthermore, during the last decade there have tremendous strides in the identification of genetic mutations associated with numerous entities, such as Alagille syndrome and bile duct paucity[1, 2], the group of disorders referred to as progressive familial cholestasis[3-5], neonatal sclerosing cholangitis[6], lymphedema-cholestasis syndrome[7], the tricho-hepato-enteric syndrome[8] and fibrocystic disorders associated with nephronophthisis[9, 10]. More recently described disorders have also been added to the differential diagnosis of the jaundiced infant, such as citrin deficiency [11] and mutations of HNF1B[12]. The goal of this symposium is to provide a conceptual approach to the differential diagnosis of cholestatic liver disease, integrating advances in molecular diagnostics and immunohistochemical markers, as well as providing insight into the latest research developments that bear on our understanding of these disorders.

The broad range of disorders that can cause infantile cholestasis makes interpretation of liver biopsies challenging

The last SPP workshop pertaining to liver disease was presented in 2004-2006, but included a vast array of childhood liver diseases with a much broader scope than the current proposal and did not specifically target infantile cholestatic disorders. Increasingly, the pathologist needs to be conversant with and integrate clinical, biochemical and rapidly advancing genetic information to complement histologic observation and assist the hepatologist in the planning of further investigation and therapy. The pathologist must be familiar with the various genetic and immunohistochemical tests and their limitations in the diagnosis of hepatic cholestatic disorders.

Knowledge need: Pediatric pathologists, pediatric pathology fellows, and surgical pathologists who evaluate newborn and infant liver biopsies need a concise, diagnosis-directed, clinicopathologic Symposium on neonatal and infantile cholestatic liver disease in order to appropriately diagnose the entities that comprise this complex group of disorders.

The differential diagnosis of the jaundiced neonate and infant is broader than at any other age. The liver biopsy is a cornerstone of the diagnostic work-up of infants with jaundice, and the wide range of disorders that can cause neonatal cholestasis makes interpretation of these biopsies challenging. The timing and expediency of the workup is in addition considered crucial because outcomes for a number of diagnoses are directly linked to early intervention, most notably biliary atresia. Furthermore, during the last decade there have tremendous strides in the identification of genetic mutations associated with numerous entities, such as Alagille syndrome and bile duct paucity[1, 2], the group of disorders referred to as progressive familial cholestasis[3-5], neonatal sclerosing cholangitis[6], lymphedema-cholestasis syndrome[7], the tricho-hepato-enteric syndrome[8] and fibrocystic disorders associated with nephronophthisis[9, 10]. More recently described disorders have also been added to the differential diagnosis of the jaundiced infant, such as citrin deficiency[11] and mutations of HNF1B[12]. The goal of this symposium is to provide a conceptual approach to the differential diagnosis of cholestatic liver disease, integrating advances in molecular diagnostics and immunohistochemical markers, as well as providing insight into the latest research developments that bear on our understanding of these disorders.

The broad range of disorders that can cause infantile cholestasis makes interpretation of liver biopsies challenging

The last SPP workshop pertaining to liver disease was presented in 2004-2006, but included a vast array of childhood liver diseases with a much broader scope than the current proposal and did not specifically target infantile cholestatic disorders. Increasingly, the pathologist needs to be conversant with and integrate clinical, biochemical and rapidly advancing genetic information to complement histologic observation and assist the hepatologist in the planning of further investigation and therapy. The pathologist must be familiar with the various genetic and immunohistochemical tests and their limitations in the diagnosis of hepatic cholestatic disorders.

Competency need: Pediatric pathologists, pediatric pathology fellows, and surgical pathologists who evaluate newborn and infant liver biopsies need to be able to accurately diagnose the cause of cholestatic liver disease for a given patient in order for that infant to receive the appropriate medical therapy and/or surgical intervention and to maximize the chances for his/her best short and long term outcomes.

Performance need: Pediatric pathologists, pediatric pathology fellows, and surgical pathologists who evaluate newborn and infant liver biopsies need to implement a functional but sufficiently comprehensive diagnostic protocol in order to accurately diagnose the cause of cholestatic liver disease in a given patient.

DISCLAIMER: These materials and all other materials provided in conjunction with continuing medical education activities are intended solely for purposes of supplementing continuing medical education programs for qualified health care professionals. Anyone using the materials assumes full responsibility and all risk for their appropriate use. The SPP makes no warranties or representations whatsoever regarding the accuracy, completeness, currentness, noninfringement, merchantability or fitness for a particular purpose of the materials. In no event will the SPP be liable to anyone for any decision made or action taken in reliance on the materials. In no event should the information in the materials be used as a substitute for professional care.

Claiming CME Credit

Certificates of continuing medical education AMA PRA Category 1 Credits™ will be issued through the Society for Pediatric Pathology. CME credits will only be awarded after completion of an online evaluation form.

Questions?

Questions regarding the Spring meeting may be directed to ametzgar@staff.spponline.org phone
+1-847-686-2365.


Mouseover to pause image slideshow

Top